Contact

What are you looking for?

Trends and Innovations in Respiratory Drug Development

July 03, 2017
Download Now

For years, the development of drugs for respiratory diseases, mainly asthma and chronic obstructive pulmonary disease (COPD), have relied on the administration of a new drug, mostly by inhalation and assessment by physiologic tests and questionnaires. More and more these new drugs are administered in fixed combinations.

This white paper outlines the latest respiratory R&D trends encompassing outcomes and clinical trial study designs.

Trends

Please complete the form to download your copy.

    Related White Papers

    News & Insights

    • SGS Headquarters

    1 Place des Alpes,

    P.O. Box 2152 1211,

    Geneva Switzerland